Roubaix Capital, LLC Haemonetics Corp Transaction History
Roubaix Capital, LLC
- $160 Million
- Q1 2025
A detailed history of Roubaix Capital, LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Roubaix Capital, LLC holds 73,652 shares of HAE stock, worth $4.87 Million. This represents 2.92% of its overall portfolio holdings.
Number of Shares
73,652Holding current value
$4.87 Million% of portfolio
2.92%Shares
1 transactions
Others Institutions Holding HAE
# of Institutions
352Shares Held
53.3MCall Options Held
417KPut Options Held
314K-
Black Rock Inc. New York, NY5.96MShares$394 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$337 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY4.35MShares$287 Million0.24% of portfolio
-
Wellington Management Group LLP Boston, MA2.62MShares$173 Million0.03% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.2MShares$145 Million0.09% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.39B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...